UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current policies of non‐commercial funders towards transparency in clinical trials

European journal of clinical investigation, 2024-06, Vol.54 (6), p.e14187-n/a

Dal‐Ré, Rafael

2024

Volltextzugriff (PDF)

Off‐label prescription of BNT162b2 mRNA COVID‐19 vaccine to <5‐year‐old children in the European Union

Acta Paediatrica, 2023-02, Vol.112 (2), p.183-185

2023

Volltextzugriff (PDF)

Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?

BMC medicine, 2018-04, Vol.16 (1), p.49-49, Article 49

2018

Volltextzugriff (PDF)

Will AstraZeneca be able to provide clinical trial data on its COVID‐19 vaccine efficacy in older adults?

British journal of clinical pharmacology, 2021-05, Vol.87 (5), p.2405-2406

Dal‐Ré, Rafael

2021

Volltextzugriff (PDF)

Clinical Equipoise in COVID‐19 Vaccine Candidate Trials

Journal of clinical pharmacology, 2021-09, Vol.61 (9), p.1249-1250

Dal‐Ré, Rafael

2021

Volltextzugriff (PDF)

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach

The Lancet infectious diseases, 2022-08, Vol.22 (8), p.e231-e238

2022

Volltextzugriff (PDF)

Reporting the details of consent procedures in clinical trials

Journal of clinical epidemiology, 2020-01, Vol.117, p.150-151

2020

Volltextzugriff (PDF)

Analysis of retracted articles on medicines administered to humans

British journal of clinical pharmacology, 2019-09, Vol.85 (9), p.2179-2181

Dal‐Ré, Rafael

2019

Volltextzugriff (PDF)

Ethical concern regarding the UK PANORAMIC COVID‐19 trial

British journal of clinical pharmacology, 2022-07, Vol.88 (7), p.3537-3538

2022

Volltextzugriff (PDF)

Unperceived similarities between clinical trials and quantum physics

British journal of clinical pharmacology, 2020-02, Vol.86 (2), p.192-193

Dal–Ré, Rafael

2020

Volltextzugriff (PDF)

Plan S: Funders are committed to open access to scientific publication

European journal of clinical investigation, 2019-06, Vol.49 (6), p.e13100-n/a

Dal‐Ré, Rafael

2019

Volltextzugriff (PDF)

COVID‐19 clinical trials: Ethical and scientific consequences of the RECOVERY trial results

Basic & clinical pharmacology & toxicology, 2020-12, Vol.127 (6), p.445-447

2020

Volltextzugriff (PDF)

Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trial

Journal of evaluation in clinical practice, 2018-02, Vol.24 (1), p.258-261

Dal‐Ré, Rafael

2018

Volltextzugriff (PDF)

Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities

The Lancet infectious diseases, 2021-11, Vol.21 (11), p.e342-e347

2021

Volltextzugriff (PDF)

What Do the Terms that Describe a Clinical Trial Convey?

The American journal of medicine, 2024-07, Vol.137 (7), p.e129-e130

Dal-Ré, Rafael

2024

Volltextzugriff (PDF)

Voluntary transparency of sponsors of medicines clinical trials is exceptional

Journal of clinical epidemiology, 2024-05, Vol.169, p.111282, Article 111282

Dal-Ré, Rafael

2024

Volltextzugriff (PDF)

The International Committee of Medical Journal Editors trial data sharing requirement and participants' consent

European journal of clinical investigation, 2016-12, Vol.46 (12), p.971-975

Dal-Ré, Rafael

2016

Volltextzugriff (PDF)

The potential exploitation of research participants in high income countries who lack access to health care

British journal of clinical pharmacology, 2016-05, Vol.81 (5), p.857-864

2016

Volltextzugriff (PDF)

Is current UK transparency on clinical trials enough?

BMJ (Online), 2023-08, p.p1933

Dal-Ré, Rafael

2023

Volltextzugriff (PDF)

Waivers of informed consent in research with competent participants and the Declaration of Helsinki

European journal of clinical pharmacology, 2023-04, Vol.79 (4), p.575-578

Dal-Ré, Rafael

2023

Volltextzugriff (PDF)

Is “interventional trial” a correct term to use in clinical research?

European journal of clinical pharmacology, 2024-07, Vol.80 (7), p.1107-1109

Dal-Ré, Rafael

2024

Volltextzugriff (PDF)

COVID-19 drug research and the cohort multiple randomised controlled trial design

The European respiratory journal, 2022-09, Vol.60 (3), p.2200746

Dal-Ré, Rafael

2022

Volltextzugriff (PDF)

Journal editors impasse with outcome reporting bias

European journal of clinical investigation, 2015-09, Vol.45 (9), p.895-898

2015

Volltextzugriff (PDF)

Adherence to the International Committee of Medical Journal Editors' (ICMJE) prospective registration policy and implications for outcome integrity: a cross-sectional analysis of trials published in high-impact specialty society journals

Trials, 2018-08, Vol.19 (1), p.448-448, Article 448

2018

Volltextzugriff (PDF)

Placebo-controlled trials with COVID-19 vaccines: participants first

Journal of clinical epidemiology, 2021-10, Vol.138, p.211-212

Dal-Ré, Rafael

2021

Volltextzugriff (PDF)

1 – 25 von 311

Menü

Weitere Dienste

Einstellungen

Current policies of non‐commercial funders towards transparency in clinical trials

Off‐label prescription of BNT162b2 mRNA COVID‐19 vaccine to <5‐year‐old children in the European Union

Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?

Will AstraZeneca be able to provide clinical trial data on its COVID‐19 vaccine efficacy in older adults?

Clinical Equipoise in COVID‐19 Vaccine Candidate Trials

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach

Reporting the details of consent procedures in clinical trials

Analysis of retracted articles on medicines administered to humans

Ethical concern regarding the UK PANORAMIC COVID‐19 trial

Unperceived similarities between clinical trials and quantum physics

Plan S: Funders are committed to open access to scientific publication

COVID‐19 clinical trials: Ethical and scientific consequences of the RECOVERY trial results

Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trial

Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities

What Do the Terms that Describe a Clinical Trial Convey?

Voluntary transparency of sponsors of medicines clinical trials is exceptional

The International Committee of Medical Journal Editors trial data sharing requirement and participants' consent

The potential exploitation of research participants in high income countries who lack access to health care

Is current UK transparency on clinical trials enough?

Waivers of informed consent in research with competent participants and the Declaration of Helsinki

Is “interventional trial” a correct term to use in clinical research?

COVID-19 drug research and the cohort multiple randomised controlled trial design

Journal editors impasse with outcome reporting bias

Adherence to the International Committee of Medical Journal Editors' (ICMJE) prospective registration policy and implications for outcome integrity: a cross-sectional analysis of trials published in high-impact specialty society journals

Placebo-controlled trials with COVID-19 vaccines: participants first

Suchergebnisse filtern